Connection
Edward Ashwood to Gestational Age
This is a "connection" page, showing publications Edward Ashwood has written about Gestational Age.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.071 |
|
|
|
-
Walker B, Ashwood ER, Jackson BR, Lagrave D. A tradeoff analysis of risk cutoffs for the quadruple serum screen for Down syndrome. Prenat Diagn. 2013 Dec; 33(12):1201-6.
Score: 0.022
-
Ashwood ER, Cheng E, Luthy DA. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs. Am J Med Genet. 1987 Mar; 26(3):531-9.
Score: 0.014
-
Ashwood ER, Tait JF, Foerder CA, Franklin RW, Benedetti TJ. Improved fluorescence polarization assay for use in evaluating fetal lung maturity. III. Retrospective clinical evaluation and comparison with the lecithin/sphingomyelin ratio. Clin Chem. 1986 Feb; 32(2):260-4.
Score: 0.013
-
Erickson JA, Ashwood ER, Gin CA. Evaluation of a dimeric inhibin-A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies. Arch Pathol Lab Med. 2004 Apr; 128(4):415-20.
Score: 0.012
-
Neerhof MG, Haney EI, Silver RK, Ashwood ER, Lee IS, Piazze JJ. Lamellar body counts compared with traditional phospholipid analysis as an assay for evaluating fetal lung maturity. Obstet Gynecol. 2001 Feb; 97(2):305-9.
Score: 0.009